Antibody blockade of Thy-1 (CD90) impairsmouse cytotoxic T lymphocyte induction by anti-CD3 monoclonal antibody

被引:15
|
作者
Haeryfar, SM
Conrad, DM
Musgrave, BL
Hoskin, DW
机构
[1] Dalhousie Univ, Fac Med, Dept Microbiol & Immunol, Halifax, NS B3H 1X5, Canada
[2] Dalhousie Univ, Fac Med, Dept Pathol, Halifax, NS B3H 1X5, Canada
来源
IMMUNOLOGY AND CELL BIOLOGY | 2005年 / 83卷 / 04期
关键词
costimulation; cytokine; cytotoxicity; signal transduction; T lymphocyte; Thy-1;
D O I
10.1111/j.1440-1711.2005.01342.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Thy-1 (CD90)expressed by mouse T cells is known to have signal transducing properties,but the ability of Thy-1 to enhance cytotoxic T lymphocyte (CTL)development is not well understood. Here we show that stimulationof mouse T cells with monoclonal antibodies (mAb) to CD3, CD28 andThy-1 (clone G7), which were coimmobilized on polystyrene microbeads,resulted in a greater proliferative response than stimulation withonly anti-CD3 and anti-CD28 mAb, indicating that Thy-1 cross-linkingenhanced T cell receptor/CD28-driven T cell activation.Consistent with this finding, Thy-1 blockade with a soluble nonactivatinganti-Thy-1 mAb (clone 30-H12) inhibited anti-CD3-induced proliferationof CD4(+) and CD8(+) T cells,and the induction of cytotoxic effector cells in a dose-dependentfashion. Interleukin-2 synthesis and CD25 expression were also impairedby Thy-1 blockade. The inhibitory effect involved a defect at orbefore the level of protein kinase C activation because the additionof phorbol ester ablated the anti-Thy-1-mediated inhibition of anti-CD3-inducedT cell activation. The CTL that were induced in the presence ofblocking anti-Thy-1 mAb adhered to target cells but showed reducedexpression of granzyme B and perforin. In contrast, Fas ligand expressionand function was not affected by Thy-1 blockade. We conclude thatThy-1 signalling promotes the in vitro generation of CTLthat kill in a granule-dependent fashion.
引用
收藏
页码:352 / 363
页数:12
相关论文
共 50 条
  • [21] Thy-1 (CD90) regulates extravasation of inflammatory cells during inflammation
    Schubert, K.
    Polte, T.
    Boenisch, U.
    Schader, S.
    Holtappels, R.
    Hildebrandt, G.
    Lehmann, J.
    Simon, J. C.
    Anderegg, U.
    Saalbach, A.
    EXPERIMENTAL DERMATOLOGY, 2011, 20 (02) : 177 - 177
  • [22] Thy-1 (CD90) as a Novel Marker for Tracking in Vivo Skin Fibrosis
    Korman, Benjamin
    Paine, Ananta
    Duemmel, Stacey
    Nuzzo, Marc
    Ritchlin, Christopher
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [23] Thy-1 (CD90) promotes bone formation and protects against obesity
    Picke, Ann-Kristin
    Campbell, Graeme M.
    Blueher, Matthias
    Kruegel, Ute
    Schmidt, Felix N.
    Tsourdi, Elena
    Winzer, Maria
    Rauner, Martina
    Vukicevic, Vladimir
    Busse, Bjoern
    Salbach-Hirsch, Juliane
    Tuckermann, Jan P.
    Simon, Jan C.
    Anderegg, Ulf
    Hofbauer, Lorenz C.
    Saalbach, Anja
    SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (453)
  • [24] Interleukin-12 can replace CD28-dependent T-cell costimulation during nonspecific cytotoxic T lymphocyte induction by anti-CD3 antibody
    Makrigiannis, AP
    Musgrave, BL
    Haeryfar, SMM
    Hoskin, DW
    JOURNAL OF LEUKOCYTE BIOLOGY, 2001, 69 (01) : 113 - 122
  • [25] Anti-CD3 antibody - MacroGenics Inc
    Brown, WM
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2006, 7 (04) : 381 - 388
  • [26] Melanoma cells utilize Thy-1 (CD90) on endothelial cells for metastasis formation
    Saalbach, A.
    Schubert, K.
    Simon, J. C.
    Anderegg, U.
    EXPERIMENTAL DERMATOLOGY, 2012, 21 (03) : e43 - e44
  • [27] Thy-1/CD90 induces metastatic breast cancer cell migration.
    Brenet, M.
    Martinez, S.
    Quest, A. F.
    Leyton, L.
    MOLECULAR BIOLOGY OF THE CELL, 2017, 28
  • [28] The cell-surface glycoprotein Thy-1 (CD90) is downregulated during 3T3-L1 adipogenesis
    Gagnon, AM
    Chaar, J
    Sorisky, A
    DIABETES, 2004, 53 : A457 - A458
  • [29] CD90/Thy-1, a Cancer-Associated Cell Surface Signaling Molecule
    Sauzay, Chloe
    Voutetakis, Konstantinos
    Chatziioannou, Aristotelis
    Chevet, Eric
    Avril, Tony
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2019, 7
  • [30] ANTI-CD3 MONOCLONAL-ANTIBODY THERAPY - AN APPROACH TOWARD OPTIMIZATION BY INVITRO ANALYSIS OF NEW ANTI-CD3 ANTIBODIES
    WOODLE, ES
    THISTLETHWAITE, JR
    JOLLIFFE, LK
    FUCELLO, AJ
    STUART, FP
    BLUESTONE, JA
    TRANSPLANTATION, 1991, 52 (02) : 361 - 368